Recent Publications by National Institute of Oncology: |
Turning laboratory findings into therapy: a marathon goal that has to be reached.
The mission of translational research involves difficult tasks to be... | 7th November, 2009
| Center of Surgical and Molecular Tumor Pathology, National Institute of
| Pol Arch Med Wewn. 2009 Sep;119(9):586-94.
|
Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
PURPOSE: To prove that 5-FU cytotoxicity could be increased by combination... | 16th October, 2009
| Department of Clinical Research, National Institute of Oncology, Budapest,
| Cancer Chemother Pharmacol. 2009 Oct 15.
DOI Direct Link |
Choroidal metastasis from tubulopapillary renal cell carcinoma: a case report.
Choroidal metastases from renal carcinoma are rare. Most reported cases... | 16th October, 2009
| Department of Medical Oncology, National Institute of Oncology Rabat
| Cases J. 2009 Jun 29;2:6618.
DOI Direct Link |
Co-inhibition of cyclooxygenase-2 and dihydropyrimidine dehydrogenase by non-steroidal anti-inflammatory drugs in tumor cells and xenografts.
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) may be able to... | 1st October, 2009
| National Institute of Oncology, Rath Gy. str. 7-9, Budapest H-1122,
| Anticancer Res. 2009 Aug;29(8):3095-101.
|
Ribavirin acts via multiple pathways in inhibition of leukemic cell proliferation.
The aim of this study was to elucidate the anticancer activity of... | 25th September, 2009
| National Institute of Oncology, Department of Molecular Genetics, H-1122
| Anticancer Res. 2009 Jun;29(6):1971-80.
|
Spatial analysis of breast and cervical cancer incidence in small geographical areas in Cuba, 1999-2003.
According to the data from the National Cancer Registry, breast and... | 16th September, 2009
| Section of Data Management and Biostatistics, Clinical Trials Department,
| Eur J Cancer Prev. 2009 Sep;18(5):395-403.
DOI Direct Link |
Small cell carcinoma of the urinary bladder: a case report and review of the literature.
Small cell carcinoma of the bladder (SCCB) is extremely rare. In this... | 2nd September, 2009
| Department of Medical Oncology, National Institute of Oncology, Rabat,
| J Cancer Res Ther. 2009 Apr-Jun;5(2):133-6.
DOI Direct Link |
A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer.
Vandetanib (ZACTIMA) is a once-daily oral anticancer drug that selectively... | 7th August, 2009
| National Institute
| Cancer Biother Radiopharm. 2009 Apr;24(2):175-80.
DOI Direct Link |
Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study.
BACKGROUND: Aggressive non-melanoma skin cancer (deeply infiltrating,... | 1st August, 2009
| National Institute of Oncology and Radiobiology, Havana, Cuba.
| BMC Cancer. 2009 Jul 30;9:262.
DOI Direct Link |
Outcome of recurrent and metastatic small cell carcinoma of the bladder.
BACKGROUND: Bladder small cell carcinoma is an uncommon tumour. Through a... | 31st July, 2009
| Department of Medical Oncology, National Institute of Oncology, Rabat,
| BMC Urol. 2009 Jun 6;9:4.
DOI Direct Link |
Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosis.
Small cell carcinoma of the bladder (SCCB) is rare, highly aggressive and... | 25th July, 2009
| Department of medical oncology, national institute of oncology
| Bull Cancer. 2009 Jun;96(6):E30-44.
DOI Direct Link |
Metastatic basal cell carcinoma to the bone and bone marrow.
BACKGROUND: Basal cell carcinoma (BCC) is the most common carcinoma in the... | 25th July, 2009
| Department of Medical Oncology and Pathology, National Institute of
| Int J Dermatol. 2009 May;48(5):481-3.
DOI Direct Link |
Myofibroblastic sarcoma of the base of tongue. Case report and review of the literature.
BACKGROUND: Mesenchymal malignancies with myofibroblastic differentiation... | 16th July, 2009
| Department of Radiotherapy, National Institute of Oncology, Budapest,
| Strahlenther Onkol. 2009 Mar;185(3):198-201. Epub 2009 Mar 28.
DOI Direct Link |
Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status.
Nasopharyngeal carcinoma (NPC) differs from other head and neck cancers in... | 16th July, 2009
| Department of Medical Oncology, National Institute of Oncology, Rabat,
| J Cancer Res Ther. 2009 Jan-Mar;5(1):3-7.
|
Concurrent chemoradiotherapy in adjuvant treatment of breast cancer.
BACKGROUND: The optimal sequencing of chemotherapy and radiotherapy after... | 9th June, 2009
| Department of Medical Oncology, National Institute of Oncology, Rabat,
| Radiat Oncol. 2009 Apr 7;4:12.
DOI Direct Link |
